Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis

References

• ThibodeauSNBrenGSchaidDMicrosatellite instability in cancer of the proximal colonScience199326051098168198484122
   PubMed Web of Science ®Google Scholar
• NetworkCGAComprehensive molecular characterization of human colon and rectal cancerNature2012487740733033722810696
   PubMed Web of Science ®Google Scholar
• CunninghamJMChristensenERTesterDJHypermethylation of the hMLH1 promoter in colon cancer with microsatellite instabilityCancer Res19985815345534609699680
   PubMed Web of Science ®Google Scholar
• LynchHTSnyderCLShawTGHeinenCDHitchinsMPMilestones of Lynch syndrome: 1895–2015Nat Rev Cancer201515318119425673086
   PubMed Web of Science ®Google Scholar
• VasenHFWatsonPMecklinJPLynchHTNew clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCCGastroenterology199911661453145610348829
   PubMed Web of Science ®Google Scholar
• HampelHNCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancerJ Natl Compr Canc Netw2014125 suppl82983124853227
   PubMedGoogle Scholar
• BurnJGerdesAMMacraeFLong-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialLancet201137898092081208722036019
   PubMed Web of Science ®Google Scholar
• LynchHTDrescherKKnezeticJLanspaSGenetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a reviewCurr Treat Options Oncol201415342944224827900
   PubMedGoogle Scholar
• GryfeRKimHHsiehETTumor microsatellite instability and clinical outcome in young patients with colorectal cancerN Engl J Med20003422697710631274
   PubMed Web of Science ®Google Scholar
• PhippsAILimburgPJBaronJAAssociation between molecular subtypes of colorectal cancer and patient survivalGastroenterology201514817787.e225280443
   PubMed Web of Science ®Google Scholar
• MalesciALaghiLBianchiPReduced likelihood of metastases in patients with microsatellite-unstable colorectal cancerClin Cancer Res200713133831383917606714
   PubMed Web of Science ®Google Scholar
• RibicCMSargentDJMooreMJTumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerN Engl J Med2003349324725712867608
   PubMed Web of Science ®Google Scholar
• SargentDJMarsoniSMongesGDefective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancerJ Clin Oncol201028203219322620498393
   PubMed Web of Science ®Google Scholar
• RothADDelorenziMTejparSIntegrated analysis of molecular and clinical prognostic factors in stage II/III colon cancerJ Natl Cancer Inst2012104211635164623104212
   PubMedGoogle Scholar
• HutchinsGSouthwardKHandleyKValue of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancerJ Clin Oncol201129101261127021383284
   PubMed Web of Science ®Google Scholar
• GoldsteinJTranBEnsorJMulticenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)Ann Oncol20142551032103824585723
   PubMed Web of Science ®Google Scholar
• BruecklWMMoeschCBrabletzTRelationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapyAnticancer Res2003232C1773177712820457
   PubMedGoogle Scholar
• BertagnolliMMNiedzwieckiDComptonCCMicrosatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and leukemia group B protocol 89803J Clin Oncol200927111814182119273709
   PubMed Web of Science ®Google Scholar
• de Vos tot Nederveen CappelWHMeulenbeldHJKleibeukerJHSurvival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancerInt J Cancer2004109346847114961589
   PubMedGoogle Scholar
• KimSTLeeJParkSHClinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapyCancer Chemother Pharmacol201066465966720033812
   PubMed Web of Science ®Google Scholar
• OhSYKimDYKimYBSuhKWOncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancerWorld J Surg201337102497250323754140
   PubMedGoogle Scholar
• SinicropeFAMahoneyMRSmyrkTCPrognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyJ Clin Oncol201331293664367224019539
   PubMed Web of Science ®Google Scholar
• VenderboschSNagtegaalIDMaughanTSMismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studiesClin Cancer Res201420205322533025139339
   PubMed Web of Science ®Google Scholar
• LeDTUramJNWangHPD-1 blockade in tumors with mismatch-repair deficiencyN Engl J Med2015372262509252026028255
   PubMed Web of Science ®Google Scholar
• FangWLChangSCLanYTMicrosatellite instability is associated with a better prognosis for gastric cancer patients after curative surgeryWorld J Surg20123692131213822669398
   PubMed Web of Science ®Google Scholar
• OkiEKakejiYZhaoYChemosensitivity and survival in gastric cancer patients with microsatellite instabilityAnn Surg Oncol20091692510251519565284
   PubMed Web of Science ®Google Scholar
• RouprêtMFromontGAzzouziARMicrosatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinomaUrology20056561233123715922421
   PubMedGoogle Scholar
• SteinbakkAMalpicaASlewaAHigh frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 casesAnal Cell Pathol (Amst)201033524525521079294
   PubMedGoogle Scholar
• SeppalaTTBohmJPFrimanMCombination of microsatellite instability and BRAF mutation status for subtyping colorectal cancerBr J Cancer2015112121966197525973534
   PubMedGoogle Scholar
• WardRLTurnerJWilliamsRRoutine testing for mismatch repair deficiency in sporadic colorectal cancer is justifiedJ Pathol2005207437738416175654
   PubMedGoogle Scholar
• MiyakuraYSuganoKKonishiFExtensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instabilityGastroenterology200112161300130911729109
   PubMedGoogle Scholar
• LaghiLBianchiPMalesciAGender difference for promoter methylation pattern of hMLH1 and p16 in sporadic MSI colorectal cancerGastroenterology2003124411651166
   PubMedGoogle Scholar
• SinicropeFAShiQSmyrkTCMolecular markers identify subtypes of stage III colon cancer associated with patient outcomesGastroenterology20151481889925305506
   PubMed Web of Science ®Google Scholar
• ClancyCBurkeJPKaladyMFCoffeyJCBRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysisColorectal Dis20131512e711e71824112392
   PubMed Web of Science ®Google Scholar
• KimHAnJYNohSHShinSKLeeYCKimHHigh microsatellite instability predicts good prognosis in intestinal-type gastric cancersJ Gastroenterol Hepatol201126358559221332554
   PubMedGoogle Scholar
• HankeyBFRiesLAEdwardsBKThe surveillance, epidemiology, and end results program: a national resourceCancer Epidemiol Biomarkers Prev19998121117112110613347
   PubMed Web of Science ®Google Scholar
• NIH [webpage on the Internet]Surveillance, Epidemiology, and End Results Program (SEER 18 2005–2011) Database Available from: http://seer.cancer.gov/statfacts/html/colorect.htmlAccessed February 8, 2017
   Google Scholar
• GolanTUrbanDBergerRLawrenceYRChanging prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor locationCancer2013119163084309123720150
   PubMed Web of Science ®Google Scholar
• KlingbielDSaridakiZRothADBosmanFDelorenziMTejparSPrognosis of stage II and III colon carcinoma treated with adjuvant 5-FU or FOLFIRI in relation to microsatellite status, results of the PETACC-3 trialAnn Oncol201526112613225361982
   PubMed Web of Science ®Google Scholar
• Des GuetzGSchischmanoffONicolasPPerretGYMorereJFUzzanBDoes microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysisEur J Cancer200945101890189619427194
   PubMed Web of Science ®Google Scholar
• OokiAAkagiKYatsuokaTCombined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancerJ Surg Oncol2014110898298825154726
   PubMed Web of Science ®Google Scholar
• von Knebel DoeberitzMKloorMTowards a vaccine to prevent cancer in Lynch syndrome patientsFam Cancer201312230731223760517
   PubMed Web of Science ®Google Scholar
• FordJMIs breast cancer a part of Lynch syndrome?Breast Cancer Res201214411022913763
   PubMedGoogle Scholar
• GrandvalPBarouk-SimonetEBronnerMIs the controversy on breast cancer as part of the Lynch-related tumor spectrum still open?Fam Cancer201211468168322890886
   PubMedGoogle Scholar
• WinAKLindorNMJenkinsMARisk of breast cancer in Lynch syndrome: a systematic reviewBreast Cancer Res2013152R2723510156
   PubMed Web of Science ®Google Scholar
• HarknessEFBarrowENewtonKLynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort studyJ Med Genet201552855355626101330
   PubMedGoogle Scholar